selected scholarly activity
-
journal articles
- Level of expression of MHCI-presented neoepitopes influences tumor rejection by neoantigen-specific CD8+ T cells.. Cancer immunology research. 2024
- Pyroptosis activates conventional type I dendritic cells to mediate the priming of highly functional anticancer T cells. Journal for ImmunoTherapy of Cancer. 12:e006781-e006781. 2024
- Determinants for Antitumor and Protumor Effects of Programmed Cell Death. Cancer immunology research. 12:7-16. 2024
- Adaptation of transgene mRNA translation boosts the anticancer efficacy of oncolytic HSV1. Journal for ImmunoTherapy of Cancer. 11:e006408-e006408. 2023
- LAMP3/CD63 Expression in Early and Late Endosomes in Human Vaginal Epithelial Cells Is Associated with Enhancement of HSV-2 Infection. Journal of Virology. 96:e0155322. 2022
- Viral-mediated activation and inhibition of programmed cell death. PLoS Pathogens. 18:e1010718-e1010718. 2022
- A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent Manner. International Journal of Molecular Sciences. 23:1754-1754. 2022
- Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells. Communications Biology. 4:859. 2021
- TRIM26 Facilitates HSV-2 Infection by Downregulating Antiviral Responses through the IRF3 Pathway. Viruses. 13:70-70. 2021
- Tumor-intrinsic determinants of immunogenic cell death modalities. OncoImmunology. 10:1893466. 2021
- Cytokines in oncolytic virotherapy. Cytokine and Growth Factor Reviews. 56:4-27. 2020
- De novo necroptosis creates an inflammatory environment mediating tumor susceptibility to immune checkpoint inhibitors. Communications Biology. 3:645. 2020
- Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning. Journal for ImmunoTherapy of Cancer. 8:e000981-e000981. 2020
- Genetic modification of oncolytic viruses to enhance antitumor immunity. Methods in Enzymology. 635:231-250. 2020
- Pre-surgical neoadjuvant oncolytic virotherapy confers protection against rechallenge in a murine model of breast cancer. Scientific Reports. 9:1865. 2019
- Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors. OncoImmunology. 7:e1503032-e1503032. 2018
- Active-site mTOR inhibitors augment HSV1-dICP0 infection in cancer cells via dysregulated eIF4E/4E-BP axis. PLoS Pathogens. 14:e1007264-e1007264. 2018
- HDACi Delivery Reprograms Tumor-Infiltrating Myeloid Cells to Eliminate Antigen-Loss Variants. Cell Reports. 24:642-654. 2018
- Critical Interactions between Immunogenic Cancer Cell Death, Oncolytic Viruses, and the Immune System Define the Rational Design of Combination Immunotherapies. Journal of Immunology. 200:450-458. 2018
- Genome-wide lentiviral shRNA screen identifies serine/arginine-rich splicing factor 2 as a determinant of oncolytic virus activity in breast cancer cells. Oncogene. 35:2465-2474. 2016
- The Role of Oncolytic Virus Immunotherapies to Subvert Cancer Immune Evasion. Future Oncology. 11:675-689. 2015
- Consensus guidelines for the detection of immunogenic cell death. OncoImmunology. 3:e955691-e955691. 2014
- Oncolytic Virotherapy and Immunogenic Cancer Cell Death: Sharpening the Sword for Improved Cancer Treatment Strategies. Molecular Therapy. 22:251-256. 2014
- Immunogenic HSV-mediated Oncolysis Shapes the Antitumor Immune Response and Contributes to Therapeutic Efficacy. Molecular Therapy. 22:123-131. 2014
- Rewiring cancer cell death to enhance oncolytic viro-immunotherapy. OncoImmunology. 2:e27138-e27138. 2013
- Combining Oncolytic HSV-1 with Immunogenic Cell Death-Inducing Drug Mitoxantrone Breaks Cancer Immune Tolerance and Improves Therapeutic Efficacy. Cancer immunology research. 1:309-319. 2013
- Oncolytic bovine herpesvirus type 1 infects and kills breast tumor cells and breast cancer-initiating cells irrespective of tumor subtype. Cancer Gene Therapy. 20:282-289. 2013
- Countermeasures against viral diseases of farmed fish. Antiviral Research. 95:257-281. 2012
- The fight between the teleost fish immune response and aquatic viruses. Molecular Immunology. 47:2525-2536. 2010
- Infectious salmon anaemia virus (ISAV) isolates induce distinct gene expression responses in the Atlantic salmon (Salmo salar) macrophage/dendritic-like cell line TO, assessed using genomic techniques. Molecular Immunology. 46:2955-2974. 2009
- Structural and functional studies of an IRF-7-like gene from Atlantic salmon. Developmental and Comparative Immunology. 33:18-27. 2009
- Absolute quantitation of infectious salmon anaemia virus using different real-time reverse transcription PCR chemistries. Journal of Virological Methods. 154:128-134. 2008
- Infectious salmon anaemia virus replication and induction of alpha interferon in Atlantic salmon erythrocytes. Virology Journal. 5:36. 2008
- Demonstration of infectious salmon anaemia virus (ISAV) endocytosis in erythrocytes of Atlantic salmon. Virology Journal. 4:13. 2007